✦ LIBER ✦

A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression

✍ Scribed by J.-M. Vanelle; S. Douki

Book ID: 118437726
Publisher: Elsevier Science
Year: 2006
Tongue: French
Weight: 327 KB
Volume: 21
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2006.09.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The treatment of negative symptoms and d

The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial

✍ Y. Lecrubier; P. Quintin; M. Bouhassira; E. Perrin; S. Lancrenon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Reboxetine versus imipramine in the trea

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial

✍ C. Katona; E. Bercoff; E. Chiu; P. Tack; M. Versiani; H. Woelk 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Flutrimazole shampoo 1%versus ketoconazo

Flutrimazole shampoo 1%versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial

✍ D. Rigopoulos; S. Gregoriou; G. Kontochristopoulos; A. Ifantides; A. Katsambas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

Efficacy and tolerability of venlafaxine

Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram

✍ Per Allard; Lars Gram; Kristina Timdahl; Kirsten Behnke; Martin Hanson; Jesper S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract ## Background The objectives of the study were to compare efficacy and tolerability of venlafaxine ER 75–150 mg/day with that of citalopram 10–20 mg/day in elderly patients with major depression according to DSM‐IV criteria. ## Methods A randomised, double‐blind, parallel group 6‐mon

Pramipexole for the treatment of depress

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

✍ Paolo Barone; Werner Poewe; Stefan Albrecht; Catherine Debieuvre; Dan Massey; Ol 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 219 KB

The prevalence of tardive dyskinesia aft

The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders

✍ Jair de Jesus Mari; M. S. Lima; A. Niccolai Costa; N. Alexandrino; S. Rodrigues– 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 208 KB